Suppr超能文献

难治性青光眼双板管手术失败的危险因素:25年手术经验

Risk Factors for Failure in Double-Plate Tube Surgery for Refractory Glaucoma: 25 Years Surgical Experience.

作者信息

Duch Susana, A Arciniegas-Perasso Carlos, Piludu Stefania, Djavanmardi Shirin, Milla Elena

机构信息

Department of Ophthalmology, Innova Ocular ICO-Barcelona, Barcelona, Spain.

出版信息

Clin Ophthalmol. 2021 Feb 9;15:461-472. doi: 10.2147/OPTH.S292150. eCollection 2021.

Abstract

PURPOSE

To investigate risk factors associated with success and failure in double-plate tube surgery.

METHODS

This retrospective case-series observational study included 243 consecutive eyes that underwent anterior-segment double-plate tube surgery from 1990 to 2015. Evaluation of the efficacy of the device was based on the final intraocular pressure (IOP) and the need for anti-glaucoma medication. We also assessed success and failure according to risk factors for trabeculectomy and an early hypertensive phase (HP).

RESULTS

Preoperative IOP was 37.3±13.1 mmHg (mean±SD) with 3.0±0.7 medications. After a median follow-up of 44.3 months, the mean IOP was 14.6±6.3 mmHg with 0.4±1.0 medications. The final IOPs ranged from 6 to 21 mmHg in 87.24% of eyes; however, 25.47% required medication. No risk factors studied were associated with surgical failure. Preoperative IOP, glaucoma type, previous surgery, previous anti-glaucoma drugs, implant type, and HP were associated with partial success (p<0.05). HP and preoperative use of brimonidine reduced the probability of complete success by 66.9% and 68.2%, respectively (p<0.05). HP was more likely when chronic preoperative prostaglandin analogues were administered (odds ratio [OR] 4.286; 95% confidence intervals [CI] 1.593-11.529; P=0.0039) and when the tube was located in the posterior chamber (OR 3.561; 95% CI 1.286-9.861; P=0.0145).

CONCLUSION

Tube surgery is effective and seems to be independent of the major risk factors for glaucoma surgery. However, previous surgery and some chronic preoperative drugs are related to the need for glaucoma medication to achieve the target pressure.

摘要

目的

探讨双板管手术成功与失败的相关危险因素。

方法

本回顾性病例系列观察性研究纳入了1990年至2015年间连续接受前段双板管手术的243只眼。根据最终眼压(IOP)和抗青光眼药物的使用需求评估该装置的疗效。我们还根据小梁切除术的危险因素和早期高血压期(HP)评估了手术的成功与失败情况。

结果

术前眼压为37.3±13.1 mmHg(均值±标准差),使用3.0±0.7种药物。中位随访44.3个月后,平均眼压为14.6±6.3 mmHg,使用0.4±1.0种药物。87.24%的患眼最终眼压在6至21 mmHg之间;然而,25.47%的患眼需要使用药物。所研究的危险因素均与手术失败无关。术前眼压、青光眼类型、既往手术、既往抗青光眼药物、植入物类型和高血压期与部分成功相关(p<0.05)。高血压期和术前使用溴莫尼定分别使完全成功的概率降低了66.9%和68.2%(p<0.05)。术前长期使用前列腺素类似物(优势比[OR] 4.286;95%置信区间[CI] 1.593 - 11.529;P = 0.0039)以及引流管位于后房时(OR 3.561;95% CI 1.286 - 9.861;P = 0.0145),高血压期更易出现。

结论

引流管手术是有效的,且似乎与青光眼手术的主要危险因素无关。然而,既往手术和一些术前长期使用的药物与达到目标眼压所需使用抗青光眼药物有关。

相似文献

1
Risk Factors for Failure in Double-Plate Tube Surgery for Refractory Glaucoma: 25 Years Surgical Experience.
Clin Ophthalmol. 2021 Feb 9;15:461-472. doi: 10.2147/OPTH.S292150. eCollection 2021.
5
Retrobulbar tube shunt: anterior chamber to back of the eye (A2B) efficacy in glaucomatous eyes with uncontrolled IOP.
Graefes Arch Clin Exp Ophthalmol. 2021 Mar;259(3):705-714. doi: 10.1007/s00417-020-05006-x. Epub 2020 Nov 11.
6
Treatment Outcomes Using the PAUL Glaucoma Implant to Control Intraocular Pressure in Eyes with Refractory Glaucoma.
Ophthalmol Glaucoma. 2020 Sep-Oct;3(5):350-359. doi: 10.1016/j.ogla.2020.05.001. Epub 2020 May 11.
7
10
Membrane-tube-type glaucoma shunt device for refractory glaucoma surgery.
Graefes Arch Clin Exp Ophthalmol. 2017 Jan;255(1):163-169. doi: 10.1007/s00417-016-3510-z. Epub 2016 Oct 20.

引用本文的文献

1
Paul versus Baerveldt 350 glaucoma drainage implants: One-year comparative analysis.
Indian J Ophthalmol. 2025 Mar 1;73(Suppl 2):S317-S323. doi: 10.4103/IJO.IJO_2595_24. Epub 2025 Feb 21.
3
Surgical Repair of the Extrusion of the Body of a PAUL Implant for Glaucoma.
Case Rep Ophthalmol. 2022 Aug 31;13(2):671-677. doi: 10.1159/000525985. eCollection 2022 May-Aug.

本文引用的文献

1
Etiology and management of the hypertensive phase in glaucoma drainage-device surgery.
Surv Ophthalmol. 2019 Mar-Apr;64(2):217-224. doi: 10.1016/j.survophthal.2018.10.008. Epub 2018 Nov 3.
2
Efficacy of glaucoma drainage devices in uveitic glaucoma and a meta-analysis of the literature.
Graefes Arch Clin Exp Ophthalmol. 2019 Jan;257(1):143-151. doi: 10.1007/s00417-018-4156-9. Epub 2018 Oct 11.
4
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
Ophthalmology. 2018 May;125(5):650-663. doi: 10.1016/j.ophtha.2018.02.003. Epub 2018 Feb 21.
5
Aqueous shunts for glaucoma.
Cochrane Database Syst Rev. 2017 Jul 28;7(7):CD004918. doi: 10.1002/14651858.CD004918.pub3.
6
Practice Preferences for Glaucoma Surgery: A Survey of the American Glaucoma Society.
J Glaucoma. 2017 Aug;26(8):687-693. doi: 10.1097/IJG.0000000000000720.
7
Iris Damage Is Associated With Elevated Cytokine Levels in Aqueous Humor.
Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO42-BIO51. doi: 10.1167/iovs.17-21421.
8
Five-Year Pooled Data Analysis of the Ahmed Baerveldt Comparison Study and the Ahmed Versus Baerveldt Study.
Am J Ophthalmol. 2017 Apr;176:118-126. doi: 10.1016/j.ajo.2017.01.003. Epub 2017 Jan 17.
9
Factors Influencing Aqueous Proinflammatory Cytokines and Growth Factors in Uveitic Glaucoma.
PLoS One. 2016 Jan 15;11(1):e0147080. doi: 10.1371/journal.pone.0147080. eCollection 2016.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验